Drug Type Molecular glue |
Synonyms HQ461 |
Target |
Mechanism CCNK degraders(cyclin K degraders), CDK12 inhibitors(cyclin dependent kinase 12 inhibitors), DDB1 inhibitors(damage specific DNA binding protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 17 Aug 2020 |